- Like, Share, or Comment:
Blog/Industry News
Understanding the New FinCEN Beneficial Ownership Reporting Rule: Massive Implications for...
By: Christopher A. Parrella, Esq., CPC, CHC, CPCO Parrella Health Law, Boston, Ma. A Health Care Defense and Compliance Firm As a healthcare defense and compliance attorney at Parrella Health Law, it's crucial to understand the implications of the...
Read More ›
1099 or W2: Navigating the New Final Rule on Worker Classification
Date: January 10, 2024 By: Christopher A. Parrella, Esq., CPC, CPCO, CHC Parrella Health Law, Boston, Ma. A Health Care Defense and Compliance Firm The U.S. Department of Labor (DOL) has issued a pivotal final rule, effective March 11, 2024,...
Read More ›
Introducing New Medicare Billing Guidelines for IOP Services: Effective January 2024
By: Christopher A. Parrella, Esq., CPC, CPCO, CHC Parrella Health Law, Boston, Ma. Parrella Health Law is pleased to announce an important update in Medicare billing for Intensive Outpatient Program (IOP) services, effective January 1, 2024. This...
Read More ›
Navigating HIPAA Compliance: Lessons from Optum Medical Care’s Settlement with OCR
Christopher A. Parrella, Esq., CPC, CPCO, CHC Parrella Health Law, Boston, Ma. Date: January 4, 2024 Introduction: The recent settlement between Optum Medical Care and the Office for Civil Rights (OCR) of the U.S. Department of Health and Human...
Read More ›
OIG’s Green Light on Physician Retirement Incentives: Analyzing the Advisory Opinion...
By: Christopher A. Parrella, Esq., CPC, CPCO, CHC Parrella Health Law, Boston, Ma. The OIG Advisory Opinion No. 23-12, issued on December 28, 2023, and posted on January 3, 2024, examines a specific arrangement proposed by a requestor involving a...
Read More ›
Embracing Modern Data: FDA’s New Guidance on Real-World Evidence for Medical...
By: Christopher A. Parrella, Esq., CPC, CHC, CPCO Parrella Health Law, Boston, Ma. The U.S. Food and Drug Administration (FDA) recently issued draft guidance clarifying the evaluation of real-world data (RWD) for regulatory decision-making...
Read More ›